Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologicsAlan Menter, Craig A. Elmets, Bruce Strober et al.|Journal of the American Academy of Dermatology|2019Cited by 917
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbiditiesCraig A. Elmets, Alan Menter, Mark Lebwohl et al.|Journal of the American Academy of Dermatology|2019Cited by 484
Comparison of Biologics and Oral Treatments for Plaque PsoriasisApril W. Armstrong, Matthias Augustin|JAMA Dermatology|2020Cited by 278
The time to offer treatments for COVID-19Binh Ngo, Ivan Fan‐Ngai Hung, Paul E. Marik et al.|Expert Opinion on Investigational Drugs|2021Cited by 32
Deucravacitinib: A Novel TYK2 Inhibitor for the Treatment of Moderate-to-Severe PsoriasisPaige Kingston, April W. Armstrong, Andrew Blauvelt et al.|Journal of Psoriasis and Psoriatic Arthritis|2023Cited by 25